08 November 2023 AdAlta: OVERSUBSCRIBED PLACEMENT RAISES A$1.65 MILLION TO PROGRESS CLINCIAL TRIAL, PARTNERING FROM INSTITUTIONAL AND SOPHISTICATED INVESTORS 0 minute read Pharma/Biotech By Cate Swannell Previous Post Next Post